Together, these results suggest that it has either been difficult to distinguish primary from secondary effects caused by loss of Alk1/Endoglin signaling or that distinct mechanisms trigger arteriovenous malformations depending on the tissue and/or vascular bed analyzed. The gene discussed is ACVRL1; the disease is arteriovenous hemangioma/malformation.